Reports Library Publication
Lower GIs: Trends & Opportunities in Laxatives, Antidiarrhoeals, Probiotics, Antispasmodics & IBS remedies
20th March 2019 by Nicholas Hall Reports
• An in-depth exploration of the Lower GIs market, including Laxatives, Antidiarrhoeals, Antispasmodics & IBS remedies and Probiotics
• Landscaping 10 major markets from across the globe, with topline sales, brand performances, regulatory developments, launches and ad campaigns
• Shorter summaries of main activity and trends in additional markets, including Australia, Canada, UK, Poland and Spain
• Mid-2018 sales from newly-updated DB6, our dedicated OTC sales database
• Case studies of key brands, highlighting success factors, sales, NPD and A+P activity
• Forecast sales for all categories and countries, plus a look at what the future holds
Order this report
An essential in-depth exploration of the Lower GIs market, including Laxatives, Antidiarrhoeals, Antispasmodics & IBS remedies and Probiotics landscaping 10 major markets from across the globe, with topline sales, brand performances, regulatory developments, launches and ad campaigns
Why buy this report?
"With Lower GIs currently outperforming the consumer health market overall, our new report delves into this important growth category, picking out the underlying trends that can make or break a brand in the fiercely competitive landscape."
Nicholas Hall